Nutritional Challenges in Patients After Intestinal Autotransplantation and Ex Vivo Surgery

JPEN. Journal of Parenteral and Enteral Nutrition
Shilpa RavellaMercedes Martinez

Abstract

Intestinal autotransplantation (IATx) and ex vivo resection is a novel surgical strategy to treat patients with unresectable abdominal neoplasms involving the mesenteric root. Nutritional challenges after IATx and ex vivo surgery have not been well described. Eleven patients, aged 7-68 years (median, 49 years) underwent IATx and ex vivo resection at our center from 2009 to 2016. A retrospective chart review was performed to evaluate nutrition status, tolerance of an oral diet, and need for parenteral nutrition (PN) and enteral (EN) nutrition. These factors were assessed preoperatively and at 3 months postoperatively. Prior to surgery, 10 of 11 patients were tolerating oral diets without need for additional PN or EN. Postoperatively, PN was initiated in all patients from 1-15 days after surgery (median, 5 days) and continued from 12-122 days (median, 32.5 days), except for of 1 patient who underwent a total enterectomy and required subsequent allotransplantation with ongoing PN. EN was initiated in 9 patients from 4-117 days after surgery (median, 17 days) and has been ongoing in 5 patients. Oral diets were initiated in all patients from 5-115 days (median, 14 days) postoperatively; at 3 months, 11 of 12 patients were tolerating...Continue Reading

References

Jul 25, 2000·Nutrition·S P Allison
May 27, 2003·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·M Isabel T D Correia, Dan L Waitzberg
May 16, 2006·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·A WeimannUNKNOWN ESPEN (European Society for Parenteral and Enteral Nutrition)
Apr 10, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Rodrigo M Vianna, Richard S Mangus

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
L G FalenderF A Williams
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Pei-ren WuZhi-ming Zhang
Nihon rinsho. Japanese journal of clinical medicine
T TsuruH Mizote
© 2022 Meta ULC. All rights reserved